GENERATIONAL EQUITY

CENTRAL JUNE 25

Issue link: http://deals.uberflip.com/i/1535904

Contents of this Issue

Navigation

Page 112 of 191

Premier Multi-Location OBGYN Practice - Georgia #68384 Sign NDA ► Revenue / EBITDA DISCLAIMER: All information contained in this document has been provided by the subject company to Generational Equity and while believed to be correct has not been verified. Accordingly, Generational Equity makes no representations or warranties as to the accuracy and truthfulness of such information. The recipient hereof acknowledges that Generational Equity shall not be liable for any loss or injury suffered by said recipient in any way connected to the delivery by Generational Equity of this document. At all times Generational Equity and its affiliate network members is an agent for the seller and not for the buyer. Generational Equity's fees are paid by the seller. Julie Sandoval Senior Managing Director - M&A Email: jsandoval@generational.com Office: 678-646-6704 Generational Equity 11175 Cicero Dr. Suite 100 Alpharetta, GA 30022 www.Generational.com I www.DealForce.com BUSINESS HIGHLIGHTS The Company is a private women's health clinic with four locations, offering a comprehensive range of services tailored to women's health needs. Staffed by two physicians, three midwives, and one nurse practitioner, the clinic provides expert care in areas such as menopause management, infertility, family planning, STD and STI treatment, preconception counseling, high-risk pregnancy, pregnancy care and delivery, and minimally invasive surgery. With a strong clinical team and a broad service offering, the Company has established itself as a trusted provider, delivering high-quality, personalized care across its communities. Its patient-first approach and consistent outcomes have fostered long-term relationships and a loyal patient base, positioning the clinic for continued growth and expansion. INVESTMENT BANK OF THE YEAR 2016 - 2017 - 2018 - 2022 - 2024 COMPANY STATS >18+ Years of Operations >70% Rate of Repeat Business >No Customer Concentration >Located in Southeast US >Operates 4 Locations >22 FT Employees >3 Doctors >Outside Major Metropolitan Area >Low CapEx Requirements >S Corporation INVESTMENT APPEAL • Strong Financial Performance: The Company has demonstrated exceptional financial performance, with historical sales increasing from $4.3 million in 2023 to $4.9 million in 2024, representing an annual growth rate of 14.0%. Additionally, EBITDA margins have improved increasing from 34.9% in 2023 to 40.8% in 2024, highlighting the Company's ability to efficiently scale. • Highly Scalable: The current facilities are well-equipped for scalable growth, with the capacity to add two additional OBGYNs without requiring new infrastructure. Each new physician can manage a team of four midwives and four nurse practitioners, significantly expanding patient care capacity. Expanding the number of providers would allow the Company to capitalize on its existing waitlist, efficiently accommodating more patients while simultaneously reducing wait times. This not only enhances the overall patient experience but also boosts satisfaction and encourages long-term loyalty and repeat visits. • Superior Name and Reputation: The Company has built a strong reputation for delivering high-quality care and outstanding patient support. Its deep expertise in handling complex patient needs has made it a trusted provider in the community and a go-to resource for comprehensive, compassionate care. • Recession-Resistant Industry: The Company's healthcare services are recession- resistant, with demand remaining stable regardless of economic conditions. As care is essential, the Company does not experience significant fluctuations in service demand, ensuring consistent performance and financial reliability GROWTH OPPORTUNITY >Geographic Expansion >Hire additional Doctors >Increase Sales & Marketing Historical & Projected Financial Performance ($ In Millions) 2024 Revenue Mix $4.9M 2024 Revenue $5.3M 2025 Revenue (Projected) (8.2% YoY Growth) $2.0M 2024 EBITDA (40.8% of Sales) $2.4M 2025 EBITDA (Projected) (45.3% of Sales)

Articles in this issue

Links on this page

Archives of this issue

view archives of GENERATIONAL EQUITY - CENTRAL JUNE 25